Successful Repair of Aortic and Mitral Incompetence Induced by Methylsergide Maleate: Confirmation by Intraoperative Transesophageal Echocardiography

@article{Joseph2003SuccessfulRO,
  title={Successful Repair of Aortic and Mitral Incompetence Induced by Methylsergide Maleate: Confirmation by Intraoperative Transesophageal Echocardiography},
  author={Thomas Joseph and Stanley K C Tam and Brinda R. Kamat and Judy R. Mangion},
  journal={Echocardiography},
  year={2003},
  volume={20}
}
Methylsergide maleate, an effective anti‐migraine medication, has a well‐documented association with left‐sided cardiac valve dysfunction. Prior reports have described cardiac valve dysfunction in patients using methylsergide chronically for a minimum of 6 years, with surgical intervention consisting of valve replacement for patients with intractable congestive heart failure. We report a 51‐year‐old woman who developed severe mitral and aortic valvular dysfunction after taking methylsergide… 

Role of echocardiography in toxic heart valvulopathy.

This review focuses on different aspects of this distinct valvulopathy in seven sections: its historical background, its morphological and echocardiographic features, its drugs associated with VHD, the influence of cumulative drug dose and risk factors, the natural course of toxic valVulopathy, and practical recommendations when using potentialValvulopathic drugs.

Valvular heart disease associated with long-term treatment by methysergide: a case report.

The echocardiographic and histological features of the severe valve fibrosis presented by this patient are very similar to those described with 5 HT(2B) receptors agonistic drugs.

Valvular Heart Disease and Postoperative Considerations

Characteristics of valvular pathologies and postoperative concerns for each the 4 cardiac valves are discussed.

Role of serotoninergic pathways in drug-induced valvular heart disease and diagnostic features by echocardiography.

Patient reported effic acy of the use of Botulinum toxin type A in the treatment of chronic migraine headaches

Patient quality of life change, duration and frequency headache improvement are the primary focus and considerations included the cost difference between the previous use of other treatment and the periodic treatment with Botulinum toxin type-A.

Patient Reported Efficacy of Botulinum Toxin Type A in the Treatment of Chronic Migraine Headaches

Patient quality of life change, duration and frequency headache improvement are the primary focus and considerations included the cost difference between the previous use of other treatment and the periodic treatment with Botulinum toxin type-A.

Multipotent and Poly-therapeutic Fungal Alkaloids of Claviceps purpurea

Ergot alkaloids and other constituents derived from Claviceps are beneficial for various clinical applications in humans and animals, however, they also contain certain chemicals that are extremely addictive, abusive, and lethal.

Microdosing psychedelics: More questions than answers? An overview and suggestions for future research

It is concluded that while most anecdotal reports focus on the positive experiences with microdosing, future research should also focus on potential risks of (multiple) administrations of a psychedelic in low doses, and (pre)clinical studies including biological as well as cognitive parameters have to be conducted to shed light on the potential negative consequencesmicrodosing could have.

Stellenwert von Methysergid (Deseril®) in der prophylaktischen Therapie der Clusterkopfschmerzen anhand der internationalen Literatur und eigener Erfahrungen

Nach den vorliegenden Daten aus alteren klinischen Studien und Patientenbeobachtungen hat sich Methysergid als effektiv zur Behandlung des Clusterkopfschmerzes erwiesen, um statistisch aussagekraftige Daten gewinnen zu konnen.

Biosynthesis, total synthesis, and biological profiles of Ergot alkaloids.

References

SHOWING 1-9 OF 9 REFERENCES

Aortic and mitral valve disease induced by ergotamine therapy for migraine: a case report and review of the literature.

The similarity to lesions in carcinoid heart disease and in methysergide-associated valvular disease suggests direct stimulation of myofibroblast growth by serotonin agonist effect in a case of aortic and mitral valve disease associated with ergotamine abuse.

Mitral and aortic valve disease associated with ergotamine therapy for migraine. Report of two cases and review of literature.

Two patients are described in whom severe valvular dysfunction developed during ergotamine therapy for migraine headache, and the surgically excised mitral and aortic valves were involved by a proliferative process that was strikingly similar to lesions described in patients with carcinoid heart disease and methysergide-associatedvalvular disease.

Development of heart valve lesions during methysergide therapy.

Polyphosphate scintigraphy should be used as the principle "search weapon" both in the initial assessment of the patient with prostatic cancer and in the continuing management of the disease.

Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations.

Ergot alkaloid preparations such as ergotamine and methysergide are used to treat migraine headache and characteristic histologic features of these preparations are identified.

diac murmurs and endocardial fibrosis associated with methylsergide therapy

  • Am Heart J
  • 1974

Ergot alkaloid heart disease

  • New Types of Cardiovascular Diseases : Topics in Clinical Cardiology
  • 1994

tral and aortic valve disease associated with ergotamine therapy for migraine

  • Arch Pathol Lab Med
  • 1990